Internationale ME/CFS Fachkonferenz 2023
Internationale „ME/CFS Conference 2023 – Understand, Diagnose, Treat“ des Charité Fatigue Center, Berlin
Am 11./12. Mai 2023 haben sich international führende ME/CFS Expert*innen über den Stand der Forschung ausgetauscht. Wir veröffentlichen hier alle Vorträge der Konferenz von und für Wissenschaftler*innen und Kliniker*innen (auf Englisch). Hier unsere Ankündigung nachlesen. Bitte unterstützen Sie auch unsere Arbeit!
unterstützt von:
Day 1 - 09:00 h
Welcome - ME/CFS Conference 2023
Carmen Scheibenbogen, Charité Fatigue Center, Berlin, Germany
ME/CFS and Post-COVID Syndrome (PCS) I
Day 1 - 09:05 h
Autoimmunity to the Autonomic Nervous System: The Mechanism to Many Common Clinical Conditions (Keynote)
Yehuda Shoenfeld, Tel Aviv University, Israel
Day 1 - 09:35 h
ME/CFS as Part of the PCS Spectrum
Carmen Scheibenbogen, Charité Fatigue Center, Berlin, Germany
Diagnosis I
Day 1 - 10:00 h
Diagnosing ME/CFS – State of the Art
Uta Behrends, University Clinic/MRI TU Munich, Germany
Day 1 - 10:20 h
Autonomic Dysfunction in ME/CFS
Pawel Zalewski, Nicolaus Copernicus University, Torún, Poland
This Video will be made available when the speaker authorises its publication.
Day 1 - 10:40 h
Breathing and Muscular Dysfunction in ME/CFS
Max Liebl, Charité University Medicine, Berlin, Germany
Diagnosis II
Day 1 - 11:40 h
Brain Fog and Neurocognitive Assessment in ME/CFS
Carsten Finke, Charité University Medicine, Berlin, Germany
Day 1 - 11:55 h
Sleep Disturbance in ME/CFS
Christian Veauthier, Charité University Medicine, Berlin, Germany
Day 1 - 12:10 h
Hypermobility in ME/CFS
Peter C. Rowe, Johns Hopkins University School of Medicine, USA
Poster Talks (3 min. overview of select posters)
Day 1 - 12:30 h
Poster Presentation: blood cell deformability cytometry
Martin Kräter, Max Planck Institute, Erlangen, Germany
Day 1 - 12:34 h
Poster Presentation: COVID-19 - the ultimate nfkB rush and the crucial importance of nicotinic acetylcholine receptors
Marco Leitzke, Helios Clinic, Leisnig, Germany
Day 1 - 12:38 h
Poster Presentation: Developing a blood cell-based diagnostic test for ME/CFS, using peripheral blood mononuclear cells
Karl J. Morten, University of Oxford, UK
Day 1 - 12:42 h
Poster Presentation: Changes of the gut microbiome in CFS Patients in response to whole-body Cryotherapy
Hanna Tabisz, Nicolaus Copernicus University Toruń, Poland
This Video will be made available when the speaker authorises its publication.
Day 1 - 12:46 h
Poster Presentation: Blood immune cells of post COVID-19 syndrome patients present with distinct alterations in their transcriptional states
Charlotte Kröger, University of Bonn, Germany
Day 1 - 12:50 h
Poster Presentation: Skeletal muscle abnormalities contribute to post-exertional malaise in Long COVID
Day 1 - 12:54 h
Poster presentation: Effects of serum factors in patents with ME/CFS after COVID-19 on endothelial cell function in vitro
Kanchan Dulal, Charité University Medicine, Berlin, Germany
This Video will be made available when the speaker authorises its publication.
Day 1 - 12:58 h
Poster Presentation: Symptom persistence and biomarkers in post-COVID-19/chronic fatigue syndrome - results from a prospective observational cohort
Franziska Legler, Charité University Medicine, Berlin, Germany
Understanding I
Day 1 - 14:00 h
Assessing Endothelial Dysfunction
Francisco Westermeier, FH Joanneum University of Applied Sciences, Graz, Austria
This Video will be made available when the speaker authorises its publication.
Day 1 - 14:15 h
Optical Coherence Tomography Angiography and Cell Deformability in ME/CFS
Bettina Hohberger, University of Erlangen, Germany
Day 1 - 14:30 h
Novel Biomarkers of Endothelial Dysfunction and Angiogenesis Alterations in PCS and ME/CFS
Martina Seifert, Charité University Medicine, Berlin, Germany
Day 1 - 14:45 h
Understanding Post-Exertional Malaise (PEM)
Christian Puta, University of Jena, Germany
ME/CFS and PCS II
Day 1 - 15:00 h
Insights from ME/CFS May Help Unravel the Pathogenesis of PCS
Anthony L. Komaroff, Harvard Medical School, USA
Day 1 - 15:20 h
Predictors of ME/CFS following EBV and implications for PCS
Leonard A. Jason, DePaul University, Chicago, USA
Understanding II
This Video will be made available when the speaker authorises its publication.
Sorry, the video of this presentation is not available. The speaker did not authorise its publication.
Day 1 - 17:10 h
Mitochondrial Dysfunction and Herpesviruses in ME/CFS
Bhupesh Prusty, University of Würzburg, Germany
Treatment I
Day 2 - 09:00 h
Treating ME/CFS – State of the Art
Day 2 - 09:20 h
Multiprofessional Inpatient ME/CFS Treatment
Johannes-Peter Haas, ZSTJM Garmisch-Partenkirchen, Germany
Day 2 - 09:35 h
Neuromodulation in ME/CFS
Michael Stingl, Facharztzentrum Votivpark, Vienna, Austria
Day 2 - 09:55 h
Medical Care Situation and Stigma with ME/CFS
Laura Froehlich, FernUniversität Hagen, Germany
Treatment II
This Video will be made available when the speaker authorises its publication.
Sorry, the video of this presentation is not available. The speaker did not authorise its publication.
Day 2 - 11:20 h
Immunoadsorption in Severly Affected ME/CFS Patients
Wolfgang Ries, DIAKO Hospital, Flensburg, Germany
Day 2 - 11:40 h
Immunoadsorption in PCS and ME/CFS
Annika Elisa Stein, Charité University Medicine, Berlin, Germany
Day 2 - 11:55 h
Treating Orthostatic Intolerance in ME/CFS
Andrea Maier, University Hospital RWTH Aachen, Germany
Day 2 - 12:10 h
Vascular Targeting in ME/CFS
Klaus Wirth, University of Frankfurt / Mitodicure GmbH, Germany
German 
English 